Dear All CRO service provider:
Date: 31/12/2025
Our company, WomenX Biotech Limited has launched a product for non-invasive detection for HPV in menstrual blood. For entering the global market, we are planning obtain CE certification in the next 9 months. You are invited to submit the quotation and proposal for
CE application to WomenX Biotech Limited. Attached
please find RFQ for your reference
RFQ details could be downloaded here:
https://drive.google.com/file/d/107IAzVLHQa5vvb-urvG31C9UsetSUkXB/view?usp=sharing
The submission should be returned by email to clinical@womenx.net
with service details, a line-by-line break down of costs, company profile and client reference,_on or before 13 Jan 2025 by 23:59 (GMT+8). Late submission will not be considered.
*By submitting this form, you agree our staff will contact you through the information you provided. Your personal information collected and held by us will be used for the clinical study only.
